NewsBenzingaNeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M Benzinga 2026.10.05 13:21 (GMT+0) Open on Benzinga Other news Oracle Trending After $10 Million Investment to Keep the Nashville Symphony Playing Susquehanna Maintains Neutral on Nabors Industries, Raises Price Target to $91 Datasea Intelligent Technology Receives 180-Day Nasdaq Extension To Regain Compliance Through March 22, 2027 Brazilian Stocks Rally 14%, Eye Best Day Since 2020 After Bolsonaro's First-Round Victory Cerebras Vs. Nvidia Is Becoming an Inference Fight, Not a Chip Fight $1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today
Datasea Intelligent Technology Receives 180-Day Nasdaq Extension To Regain Compliance Through March 22, 2027
